Samuel Whiting - Jan 4, 2022 Form 4 Insider Report for Tempest Therapeutics, Inc. (TPST)

Role
Chief Medical Officer
Signature
/s/ Pierre Lorenzo, Attorney-in-Fact for Samuel Whiting
Stock symbol
TPST
Transactions as of
Jan 4, 2022
Transactions value $
$0
Form type
4
Date filed
1/6/2022, 06:25 PM
Previous filing
Jun 30, 2021
Next filing
Jan 10, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPST Stock Option (Right to Buy) Award $0 +29K $0.00 29K Jan 4, 2022 Common Stock 29K $5.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest in a series of 48 equal monthly installments measured from January 4, 2022, subject to the reporting person's continued service.